Rhythm Pharmaceuticals, Inc. Gains 31.48%
Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ) soared at $8.77, a gain of 31.5%. On Wed, Jul 13, 2022, RYTM:NASDAQ touched a New 2-Week High of $8.77. The stock appeared on our News Catalysts scanner on Wed, Jul 13, 2022 at 02:39 PM in the 'MISCELLANEOUS' category. From Wed, Jun 29, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days
About Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ)
Rhythm Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 47.15%
- ironSource Ltd. Class A (IS:NYSE), 47.09%
- TDH Holdings, Inc. (PETZ:NASDAQ), 42.23%
- NuCana plc (NCNA:NASDAQ), 41.4%
- Gossamer Bio, Inc. (GOSS:NASDAQ), 31.9%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 31.48%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 24.34%
- The OLB Group, Inc. (OLB:NASDAQ), 23.86%
- Velo3D Inc. (VLD:NYSE), 22.22%
- CinCor Pharma Inc. (CINC:NASDAQ), 21.13%